Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles*

The interaction of Alzheimer’s Aβ peptide and its fluorescent analogue with membrane vesicles was studied by spectrofluorometry, Congo Red binding, and electron microscopy. The peptide binds selectively to the membranes containing gangliosides with a binding affinity ranging from 10−6 to 10−7 m depending on the type of ganglioside sugar moiety. This interaction appears to be ganglioside-specific as under our experimental conditions (neutral pH, physiologically relevant ionic strength), no Aβ binding was observed to ganglioside-free membranes containing zwitterionic or acidic phospholipids. Importantly, the addition of ganglioside-containing vesicles to the peptide solution dramatically accelerates the rate of fibril formation as compared with that of the peptide alone. The present results strongly suggest that the membrane-bound form of the peptide may act as a specific “template” (seed) that catalyzes the fibrillogenesis processin vivo.

[1]  C. Glabe,et al.  Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations* , 1997, The Journal of Biological Chemistry.

[2]  R. Wetzel,et al.  Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. , 1996, Biochemistry.

[3]  C. Glabe,et al.  Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells , 1997, Brain Research.

[4]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[5]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[6]  R J Mark,et al.  Disruption of brain cell ion homeostasis in Alzheimer's disease by oxy radicals, and signaling pathways that protect therefrom. , 1997, Chemical research in toxicology.

[7]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[8]  M. A. Simmons,et al.  Amyloid β peptides act directly on single neurons , 1993, Neuroscience Letters.

[9]  C. Cotman,et al.  All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids* , 1997, The Journal of Biological Chemistry.

[10]  Y. Ihara,et al.  GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease , 1995, Nature Medicine.

[11]  D. Butterfield.  beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. , 1997, Chemical research in toxicology.

[12]  J. Vincent,et al.  Characteristics of angiotensin II binding sites in the neostriatum of the rat brain , 1982, Neurochemistry International.

[13]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Bruce A. Yankner,et al.  Methodological variables in the assessment of beta amyloid neurotoxicity , 1992, Neurobiology of Aging.

[15]  L. Choo-Smith,et al.  The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes , 1997, FEBS letters.

[16]  T. E. Thompson,et al.  Asymmetric incorporation of trisialoganglioside into dipalmitoylphosphatidylcholine vesicles. , 1981, Biochemistry.

[17]  H. Vinters,et al.  Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress , 1995, Acta Neuropathologica.

[18]  R. Wetzel,et al.  Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. , 1996, Journal of molecular biology.

[19]  J. Seelig,et al.  Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. , 1995, Journal of molecular biology.

[20]  W. Müller,et al.  β-amyloid peptide decreases membrane fluidity , 1995, Brain Research.

[21]  S. Rapoport,et al.  β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease , 1994, Brain Research.

[22]  Mahendra K. Jain,et al.  Interaction of phospholipase A2 and phospholipid bilayers. , 1982, Biochimica et biophysica acta.

[23]  H. Hansson,et al.  Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[25]  J. Cleary,et al.  Amyloid β‐Peptides Increase Annular and Bulk Fluidity and Induce Lipid Peroxidation in Brain Synaptic Plasma Membranes , 1997, Journal of neurochemistry.

[26]  N. Akaike,et al.  Amyloid β protein‐induced irreversible current in rat cortical neurones , 1994 .

[27]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[28]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[29]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[30]  J. McLaurin,et al.  Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides , 1996, The Journal of Biological Chemistry.

[31]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[32]  T. Good,et al.  Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. , 1996, Biophysical journal.

[33]  R. Davidson,et al.  Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells , 1994, Brain Research.

[34]  D. Perlmutter,et al.  Specificity in Recognition of Amyloid-β Peptide by the Serpin-Enzyme Complex Receptor in Hepatoma Cells and Neuronal Cells (*) , 1995, The Journal of Biological Chemistry.